Ode to the liver enzyme

December 2008
Gut;Dec2008, Vol. 57 Issue 12, p1721
Academic Journal
The article presents a study on non-alcoholic fatty liver disease (NAFLD). It states that cohort studies on this disease suggest that it is related with increased all-cause and cardiovascular mortality. It also mentions that mechanistic studies identify that NAFLD itself maybe an independent cardiovascular risk factor. The result suggested that NAFLD is a strong independent risk factor for cardiovascular death in the 45-54 age bracket.


Related Articles

  • Nonalcoholic fatty liver disease.  // Mayo Clinic Health Letter;Sep2006, Vol. 24 Issue 9, p1 

    The article presents information on nonalcoholic fatty liver disease. Commonly referred as the silent liver disease, nonalcoholic fatty liver disease is a range of liver conditions which occurred in individuals who consumed little or no alcohol at all. The symptoms associated with nonalcoholic...

  • Prevalence of non-alcoholic fatty liver disease in four different weight related patient groups: association with small bowel length and risk factors. Hillenbrand, Andreas; Kiebler, Brigitte; Schwab, Cornelia; Scheja, Ludger; Pengfei Xu; Henne-Bruns, Doris; Wolf, Anna Maria; Knippschild, Uwe // BMC Research Notes;Jul2015, Vol. 8 Issue 1, p1 

    Background: Non-alcoholic steatohepatitis (NASH) is an obesity associated common cause of liver inflammation and there are concerns that it may turn out to be the most common cause of liver failure as prevalence of obesity increases. We determined the prevalence of NASH in relation to gender and...

  • Hyperferritinemia is a risk factor for steatosis in chronic liver disease. Licata, Anna; Nebbia, Maria Elena; Cabibbo, Giuseppe; Iacono, Giovanna Lo; Barbaria, Francesco; Brucato, Virna; Alessi, Nicola; Porrovecchio, Salvatore; Di Marco, Vito; Craxì, Antonio; Cammà, Calogero; Torbenson, Michael // World Journal of Gastroenterology;5/7/2009, Vol. 15 Issue 17, p2132 

    AIM: To investigate the relationship between ferritin and steatosis in patients with chronically abnormal liver function tests (LFTs) and high ferritin level. METHODS: One hundred and twenty-four consecutive patients with hyperferritinemia (male > 300 ng/mL, female > 200 ng/mL) were evaluated;...

  • Nonalcoholic Fatty Liver Disease. Angulo, Paul // New England Journal of Medicine;4/18/2002, Vol. 346 Issue 16, p1221 

    Presents information on nonalcoholic fatty liver disease. Description of the disease; Symptoms, including obesity and type 2 diabetes mellitus; Prevalence of the disease; Way that the disease manifests itself; How the disease is diagnosed.

  • Nonalcoholic Fatty Liver Disease (NAFLD) in Saudi Patients with T2DM in Jazan Region: Prevalence and Associated Factors. Elmakki, Erwa; Aqeely, Hussein; Bani, Ibrahim; Omer, Husam; Solan, Yahya; Taher, Asim; Hadi, Talal; Mohammed, Musa; Abdalla, Saif Elden; Mahfouz, Mohammed S.; Tsan Yang // British Journal of Medicine & Medical Research;2015, Vol. 5 Issue 7, p878 

    Backgrounds: Non-alcoholic fatty liver disease (NAFLD) has become one of the major health problems world widely, especially among communities with sedentary lifestyle. The main objectives of this study were to know the prevalence of NAFLD among Saudi patients with T2DM in Jazan region and to...

  • Non-alcoholic fatty liver disease in Japanese patients.  // Clinical Cardiology Alert;Apr2010 Primary Care Supplement, Vol. 15 Issue 4, p8 

    The article discusses research on the histological course of nonalcoholic fatty liver disease in Japanese patients, which references a study by E. Hamaguchi and colleagues published in a 2010 issue of "Diabetes Care."

  • Pregnancy-Related Liver Disorders. Goel, Ashish; Jamwal, Kapil D.; Ramachandrany, Anup; Balasubramaniany, Kunissery A.; Eapen, Chundamannil E. // Experimental & Clinical Hepatology;Jun2014, Vol. 4 Issue 2, p151 

    Pregnancy-related liver disorders accounted for 8% of all maternal deaths at our center from 1999 to 2011. Of the three pregnancy-related liver disorders (acute fatty liver of pregnancy (AFLP), HELLP (Hemolysis, elevated liver enzymes, low platelets) syndrome and pre-eclamptic liver dysfunction,...

  • Transient elastography as a screening tool for liver fibrosis and cirrhosis in a community-based population aged over 45 years. Roulot, Dominique; Costes, Jean-Luc; Buyck, Jean-François; Warzocha, Ursula; Gambier, Nicolas; Czernichow, Sébastien; Le Clesiau, Hervé; Beaugrand, Michel // Gut;Jul2011, Vol. 60 Issue 7, p977 

    Background Liver stiffness measurement (LSM) has been used to measure fibrosis in patients with various types of chronic liver diseases. However, its usefulness as a screening procedure in apparently healthy people had not been evaluated to date. Methods 1358 subjects >45 years old from a...

  • Nonalcoholic fatty liver: the new component of metabolic syndrome. SIBAL, MEG // Filipino Reporter;3/20/2015, Vol. 43 Issue 16, p17 

    The article discusses a study which showed that fatty liver is a component of metabolic syndrome, common conditions that increase the risk of heart disease, stroke and diabetes. It references a research published in the February 2015 issue of the journal "Mayo Clinic Health Letter." Topics...


Read the Article


Sign out of this library

Other Topics